- £17.70m
- £42.90m
- £250.30m
- 44
- 73
- 37
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 358 | 257 | 258 | 261 | 250 |
Cost of Revenue | |||||
Gross Profit | 74.5 | 54 | 59.5 | 65.4 | 57.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 354 | 258 | 252 | 253 | 249 |
Operating Profit | 4 | -1 | 6.7 | 8.8 | 1.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.9 | -2 | 6 | 7.6 | 0.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.5 | -3.2 | 2.9 | 4.8 | -1.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.8 | -3.1 | 2.3 | 3.4 | -2.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.8 | -3.1 | 2.3 | 3.4 | -2.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.043 | 0.009 | 0.056 | 0.067 | -0.03 |
Dividends per Share |